Granules highlighted that the approved tablet is bioequivalent to the Advil® Dual Action with Acetaminophen Tablets, 250 mg/125 mg, manufactured by GlaxoSmithKline Consumer Healthcare Holdings.

Granules India on Thursday announced that it has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride Extended Release tablets. Potassium Chloride ...

Drug maker Granules India has received US Food and Drug Administration (USFDA) approval for Fexofenadine Hydrochloride tablets. In a regulatory filing with the stock exchange on Monday, the ...